Albertsons Companies Inc. (ACI) Sinks 7.48% After Earnings, Beats EPS, Revenue Falls Short
· Stocks · QuoteReporter
Post Earning Analysis
Albertsons Companies Inc. (ACI) Sinks 7.48% After Earnings, Beats EPS, Revenue Falls Short
Albertsons Cos., Inc., founded by Joe Albertson in 1939 and headquartered in Boise, Idaho, operates a chain of food and drug retail stores. The company provides a broad array of products including groceries, general merchandise, health and beauty care items, pharmacy services, fuel, and more, catering to the everyday needs of consumers.
Albertsons has recently reported a rise in sales, driven by strategic price cuts and growth in pharmacy and digital sectors, which has attracted more consumers during economically challenging times. Despite a revenue miss, Albertsons surpassed third-quarter earnings expectations, suggesting operational efficiency and possibly better-than-expected profit margins. The company also announced a common stock dividend, signaling confidence in its financial health and ongoing commitment to delivering shareholder value.
These developments could potentially bolster investor confidence in Albertsons’ stock, as the company demonstrates resilience and strategic adaptability in a competitive retail landscape. The emphasis on expanding digital and pharmacy services could further enhance its market position and long-term growth prospects. Additionally, the declaration of a dividend might attract dividend-seeking investors, potentially increasing the stock’s demand and price. Overall, these factors combined present a positive outlook for Albertsons’ stock performance in the near future.
The current price of the asset at $16.13 reflects a notable downtrend, evidenced by today’s sharp decline of 7.48%. This price is near the 52-week low of $15.80 and significantly below the 52-week high of $22.70, indicating a bearish trend over the past year. The asset is also performing poorly relative to its moving averages, trading below the 20-day, 50-day, and 200-day moving averages by 6.54%, 8.4%, and 17.28% respectively, which suggests sustained negative momentum.
The RSI at 26.27 signals that the asset is currently in the oversold territory, which might typically suggest a potential reversal or correction in price. However, the MACD at -0.22, being negative, supports the view of continuing bearish momentum.
Given these indicators, the asset appears to be facing significant downward pressure, with little immediate sign of recovery as indicated by both price trends and momentum indicators. Investors might exercise caution, looking for signs of stabilization or reversal before considering entry.
Albertsons Companies, Inc. (NYSE: ACI) reported its third-quarter fiscal 2025 results, showing a mix of growth in sales and a decline in profitability compared to the same quarter the previous year. For Q3 2025, which ended on November 29, 2025, the company saw its net sales increase by 1.9% to $19.123 billion, driven by a 2.4% rise in identical sales. Digital sales surged by 21%, and loyalty members grew by 12% to 49.8 million.
However, net income for the quarter was $293 million, or $0.55 per share, a decrease from $400.6 million, or $0.69 per share in Q3 2024. Adjusted net income was slightly higher at $390 million, or $0.72 per share. Adjusted EBITDA also saw a decline, falling to $1.039 billion from $1.065 billion in the prior year.
The company noted several financial maneuvers including a dividend payment of $0.15 per share and an accelerated $750 million share repurchase agreement. Looking ahead, Albertsons anticipates identical sales growth of 2.2% to 2.5%, adjusted EBITDA of between $3.825 billion to $3.875 billion, and adjusted net income per share in the range of $2.08 to $2.16. The effective income tax rate is expected to be between 23% and 24%.
Earnings Trend Table
| Date | Estimate EPS | Reported EPS | Surprise % | |
|---|---|---|---|---|
| 0 | 2026-01-07 | 0.67 | 0.72 | 7.46 |
| 1 | 2025-04-15 | 0.40 | 0.46 | 13.63 |
| 2 | 2025-01-08 | 0.66 | 0.71 | 8.19 |
| 3 | 2024-10-15 | 0.48 | 0.51 | 6.41 |
| 4 | 2024-07-23 | 0.67 | 0.66 | -0.86 |
| 5 | 2024-04-22 | 0.52 | 0.54 | 3.05 |
| 6 | 2024-01-09 | 0.66 | 0.79 | 19.82 |
| 7 | 2023-10-17 | 0.56 | 0.63 | 12.64 |
The provided earnings data reveals a generally positive trend in both reported EPS and EPS surprises over the observed quarters. A detailed analysis shows that the company consistently surpassed its EPS estimates in all but one quarter (Q3 2024), where it underperformed slightly by -0.86%. This deviation is minor compared to the overall trend.
The most significant positive surprise occurred in Q1 2024, with a 19.82% increase over the estimate, indicating a robust performance that significantly exceeded expectations. Other quarters, such as Q4 2023 and Q2 2025, also demonstrated strong positive surprises with 12.64% and 13.63% respectively, suggesting periods of high operational efficiency or favorable market conditions.
The trend of reported EPS generally aligns closely with the estimates, suggesting effective forecasting and stable business operations. The consistency in beating estimates, except for one instance, reflects well on the company’s financial management and predictive accuracy. Overall, the data indicates a healthy financial trajectory with the capability to meet and exceed analyst expectations.
Dividend Payments Table
| Date | Dividend |
|---|---|
| 2025-10-24 | 0.15 |
| 2025-07-25 | 0.15 |
| 2025-04-25 | 0.15 |
| 2025-01-24 | 0.15 |
| 2024-10-28 | 0.12 |
| 2024-07-26 | 0.12 |
| 2024-04-25 | 0.12 |
| 2024-01-25 | 0.12 |
The dividend data across the specified periods reveals a notable trend in the dividend payouts. In 2024, the dividends were consistently set at $0.12 each quarter, indicating a stable payout strategy during this year. However, starting from January 2025, there has been an increase in the dividend rate to $0.15 per quarter, which has been maintained throughout the subsequent quarters of that year.
This increment suggests a positive adjustment in the company’s dividend policy, possibly reflecting an improved financial performance or a strategic decision to return more capital to shareholders. The consistent payment throughout each quarter also indicates a stable financial stance and reliability in maintaining regular shareholder distributions. Such trends are crucial for investors looking for steady income streams and could potentially enhance shareholder value and attract further investment. Overall, the increase in dividends from 2024 to 2025 marks a significant shift in the company’s approach to its dividend distributions.
On August 20, 2025, JP Morgan resumed coverage on Outer with an “Overweight” rating, setting a target price of $27. This suggests JP Morgan’s analysts predict the stock will outperform the average return of the stocks they cover, reflecting a positive outlook on Outer’s future performance.
Previously, on July 22, 2025, UBS upgraded its rating on Outer from “Neutral” to “Buy,” also with a target price of $27. This upgrade indicates a shift in UBS’s view, suggesting increased confidence in Outer’s market position and expected financial performance. The alignment of the target price with JP Morgan’s later assessment underscores a consensus on Outer’s valuation at $27.
A day earlier, on July 21, 2025, Barclays initiated coverage on Outer with an “Underweight” rating and a target price of $19. This rating is significantly more conservative compared to the others, implying that Barclays expects Outer to underperform relative to its sector peers.
Lastly, on May 7, 2025, BMO Capital Markets upgraded Outer from “Market Perform” to “Outperform” with a target price of $25. This upgrade suggests that BMO Capital Markets anticipated better than average growth or valuation for Outer compared to the broader market, albeit slightly lower than the target prices set by JP Morgan and UBS.
These varied ratings and target prices reflect differing perspectives and expectations from major financial institutions regarding Outer’s market performance, highlighting the diverse analytical approaches in financial assessment.
The current price of the stock is $16.13. Analyzing the target prices provided by various analysts, there is a notable variance. JP Morgan and UBS both have a target price of $27, indicating a significant potential upside of approximately 67.5%. BMO Capital Markets also shows optimism with a target of $25, suggesting a potential increase of about 55%. On the other hand, Barclays holds a more conservative view, with a target price of $19, which still implies an estimated growth of 17.8%. This mix of perspectives from high-profile financial institutions suggests a generally positive outlook, albeit with some caution reflected in the underweight rating from Barclays.
The average target price, considering these forecasts, stands at approximately $24.5, indicating a potential average growth of 51.8% from the current price. This disparity between the current market price and the analysts’ target prices could suggest that the stock is currently undervalued, offering a potentially attractive entry point for investors.
Disclaimer: The information provided here is for educational and informational purposes only and should not be interpreted as financial advice, investment recommendations, or trading guidance. Markets involve risk, and past performance is not indicative of future results. You should always conduct your own research and consult with a qualified financial advisor before making any investment decisions. By acting, you accept full responsibility for your choices.